Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Hepatology

    - PMLiVE

    Medscape Wins Anthem Award for Rare Disease Education Platform

    Platform has reached 2.4 million healthcare professionals worldwide since 2021. Newark, NJ - [November 18, 2025] - Medscape, the leading digital platform for physicians and healthcare professionals (HCPs), has been...

    Medscape Education

    - PMLiVE

    Novo Nordisk reports phase 3 data showing semaglutide reduces liver scarring

    Patients with MASH in the ESSENCE phase 3 trial show semaglutide’s potential to improve liver health

    - PMLiVE

    Innovation in Action at AAFP FMX 2025

    This year, Medscape Education is redefining the live learning experience at AAFP FMX 2025. With 8 groundbreaking, accredited symposia, we are proud to be at the heart of the meeting,...

    Medscape Education

    - PMLiVE

    Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education

    UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...

    Medscape Education

    - PMLiVE

    Roche to acquire 89bio in a deal worth up to US$3.5bn

    With the agreement, Roche will gain a treatment for moderate to severe MASH

    - PMLiVE

    Medical Misinformation and Sensationalism in the Age of Social Media

    In today’s digital age, misinformation spreads faster than ever, often driven by sensational headlines and influencer content. These sources of misinformation often overshadow evidence-based content, creating confusion for both healthcare...

    Medscape Education

    - PMLiVE

    Medscape Education Celebrates 30 Years of Impact with Launch of The Center of Excellence for Instructional Design

    Medscape Education, a global leader in healthcare education, proudly announces the official launch of its Center of Excellence for Instructional Design—a central hub of expertise and strategic capability, dedicated to...

    Medscape Education

    - PMLiVE

    Medscape at the American Diabetes Association’s 85th Scientific Sessions: Your Sweet Spot for Innovation!

    The American Diabetes Association’s 85th Scientific Sessions is almost here, and Medscape is ready to make an impact in the world of diabetes care! With two groundbreaking symposia, 11 dynamic...

    Medscape Education

    - PMLiVE

    Medscape Celebrates Eight Groundbreaking Publications at ATS 2025 International Conference

    Medscape Education is proud to announce the presentation of eight innovative educational research publications at the American Thoracic Society (ATS) 2025 International Conference, held May 16–21 in San Francisco, CA....

    Medscape Education

    - PMLiVE

    GSK to acquire Boston’s liver disease candidate efimosfermin in deal worth up to $2bn

    Steatotic liver disease affects approximately 5% of the global population

    - PMLiVE

    Madrigal’s liver disease drug Rezdiffra shows promise in compensated MASH cirrhosis

    The drug has already been approved in the US to treat patients with non-cirrhotic MASH

    - PMLiVE

    Ipsen’s elafibranor shows promise in rare liver disease primary sclerosing cholangitis

    The drug already holds approvals to treat primary biliary cholangitis, another rare liver disease

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links